Campbell Soup Company will close its Hyannis, Massachusetts snack facility by April, consolidating production of Cape Cod and Kettle Brand chips at other US plants amid declining sales in its snacks division.
The protective packaging leader's 2025 recycling achievement, driven by customer partnerships and its EmeraldPak product, marks a significant step in its 'Stairway to Green' initiative and underscores growing industry momentum for closed-loop systems.
Reuters reveals that senior U.S. diplomats suppressed graphic cables from aid officials detailing catastrophic famine and devastation in northern Gaza in early 2024, preventing the warnings from reaching top Biden administration leadership.
A provocative art installation in Tokyo, featuring a violently thrashing robot dog restrained by a metal chain, is drawing crowds and forcing viewers to confront uneasy questions about the future of artificial intelligence, ethics, and our emotional connection to machines.
A new Congressional Budget Office analysis reveals the substantial financial burden of deploying National Guard and active-duty troops to several U.S. cities last year, with monthly costs for continued operations running into the tens of millions.
At its Analyst Day, Korro Bio detailed its lead candidate KRRO-121, an RNA-editing therapeutic designed to tackle hyperammonemia in urea cycle disorders and hepatic encephalopathy by stabilizing a key liver enzyme, positioning it as a potential paradigm shift from current burdensome treatments.
British Prime Minister Keir Starmer arrived in Shanghai Friday with over 50 business leaders, aiming to deepen UK-China commercial ties. The visit, the first by a UK premier in eight years, comes against a backdrop of renewed US skepticism over Western engagement with Beijing.
After a brutal 2025, fast-casual restaurant stocks are rallying sharply in early 2026. Analysts debate whether this marks a genuine recovery or a temporary bounce, as consumers pivot towards grocery and convenience store meals, forcing a reckoning on value and quality.
While Morgan Stanley maintains an Overweight rating on PDD Holdings, the firm has removed the e-commerce giant from its Top Picks list, citing heightened regulatory scrutiny and a slower-than-expected consumer recovery in China.
Biotech firm Argenx SE sees its flagship drug Vyvgart outperform sales expectations in myasthenia gravis and CIDP treatments, with analysts pointing to sustained growth and regulatory momentum as key drivers.
Fractyl Health's Revita procedure shows promise in maintaining weight after stopping GLP-1 drugs, with new six-month data prompting the company to seek a streamlined FDA pathway. A packed 2026 roadmap aims for a U.S. submission, but financial pressures loom.
Amidst a backdrop of geopolitical tensions and market volatility, a closer look reveals resilient European companies whose current share prices may not reflect their underlying strength and future growth prospects.
Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.
A new lawsuit alleging wrongful termination and safety cover-ups, coupled with ongoing supply shortages, challenges the coffee giant's operational resilience and brand trust as its new CEO executes a critical recovery plan.
As regional tensions weigh on major Gulf indices, a closer look reveals resilient investment opportunities among smaller, financially sound companies. From energy giants to niche manufacturers, these picks highlight value where many fear to tread.
Southeast Asian super app Grab Holdings has appointed Laura Franco to its board, succeeding the retiring Ng Shin Ein. The move signals a governance refresh aimed at steering the company's aggressive expansion into on-demand grocery, financial technology, and next-generation mobility partnerships.
In a recent interview, Robinhood CEO Vlad Tenev argues that artificial intelligence will likely reshape the workforce by creating new, unforeseen categories of employment, drawing parallels to past technological revolutions. However, he acknowledges the unprecedented speed of AI-driven change is a cause for concern.
